← Eichor
Study identifier: NCT07135037 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison Between Treatments of Oligohydramnios

Condition: Oligohydramnios  ·  Sponsor: Kafrelsheikh University

PhasePhase 2
Planned participants40
Who can joinFemale, 18 Years to 35 Years
Healthy volunteersYes

About this study

Based on previous studies, Both sildenafil and L-arginine helped to improve idiopathic oligohydramnios. In this study, Level of improvment of oligohydramnios will be compared. As well as, NICU admission to neonates of pregnancies complicated by idiopathic oligohydramnios. The end goal is to help physicians use the best drug for their patients.

This description comes directly from the study's public registry record.

Talk to the study team

Ibtesam T Gadalla, MBBch  ·  1025193157  ·  bassmagadalla@gmail.com

Mostafa F El-lakany, PHD  ·  10116083210  ·  Mfe_2014@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (2)

Kafrelsheikh University HospitalKafr ash Shaykh, Kafrelsheikh, EgyptActive Not Recruiting
Kafrelsheokh university hospitalKafr ash Shaykh, Kafrelsheikh, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07135037